期刊文献+

依达拉奉注射液治疗急性脑梗死53例临床疗效观察 被引量:2

下载PDF
导出
摘要 依达拉奉注射液为自由基清除剂,能有效阻断自由基,从而发挥脑保护作用,本文应用依达拉奉注射液治疗急性脑梗死,取得良好效果,现报告如下。1资料与方法1.1病例选择:选择2009年3月至2011年3月我院内科住院的急性脑梗死患者,入选标准:①符合全国第四届脑血管病学术会议制定标准[1],并经头颅证实,排除脑出血;
作者 续军 张卫平
出处 《实用医技杂志》 2012年第2期183-184,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献8

二级参考文献17

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33037
  • 2Knaus WA,Zimmerman JE,Wagner DP,et al.APACHEⅡ:a severity of disease classification system.Crit Care Med,1985,13:818.
  • 3Metz CE.Some practical issues of experimental design and analysis in radiological ROC studies.Invest Radiol,1989,24:234-245.
  • 4Sirio CA,Tajimi K,Knaus WA,et al.An initial comparison of intensive care in Japan and the United States.Crit Care Med,1992,20:1207-1215.
  • 5Rowan KM,Kerr JH,Major E,et al.Intensive Care Society's APACHEⅡStudy in Britain and Ireland Ⅱ:outcome comparison of intensive care units after adjustment for care mix by the American APACHEⅡ method.BMJ,1993,307:977-981.
  • 6Oh TE,Hutchinson R,Short S,et al.Verification of the acute physiology and chronic health evaluation scoring system in a Hong Kong intensive care unit.Crit Care Med,1993,21:698.
  • 7Cho DY,Wang YC.Comparison of the APACHEⅢ,APACHEⅡ and Glasgow Come Scale in acute head injury for prediction of mortality and functional outcome.Intensive Care Med,1997,23:77-84.
  • 8Jialal I,Deveraj S.Inflammation and atheroselerosis:the value of the high-sensitivity C-reactive protein in assay as a risk marker[ J ].Am J Clin Pathol,2001:116(Suppl):S108-15.
  • 9全国第4届脑血管病学术会议制定诊断标准[J].中华神经科杂志,1996,29(6):379-80.
  • 10Gabay C,Kushner I.Acute-phase proteins and other system in responses to inflammation[ J].N EngI J Med,1999; 340:448-54.

共引文献42969

同被引文献26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部